WHO ICTRP trial
a study on siddha trail drug KUTTATHIRKU CHOORANAM (INT) & VEPPAMPATTAI THYLAM…
CTRI/2018/05/013644 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/05/013644 |
|---|---|
| Public title | a study on siddha trail drug KUTTATHIRKU CHOORANAM (INT) & VEPPAMPATTAI THYLAM (EXT) & PRANAYAAMAM (THERAPY) in patients having psoriasis |
| Scientific title | AN OPEN CLINICAL TRAIL ON â??THEATHRU KUTTAM (PSORIASIS)â?? WITH THE EVALUATION ON SIDDHA HERBO-MINERAL FORMULATION KUTTATHIRKU CHOORANAM (INT) & VEPPAMPATTAI THYLAM (EXT) & PRANAYAAMAM (THERAPY). |
| Primary sponsor | government siddha medical college |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- THEATHRU KUTTAM (PSORIASIS) |
| Interventions | Intervention1: KUTTATHIRKU CHOORANAM(INT) & VEPPAMPATTAI THYLAM (EXT): 8oo mg of KUTTATHIRKKU CHOORANAM for 48 days as internal medicine and Veppampattai thylam (external) for 48 days as external medicine Control Intervention1: nil: nil |
| Registration date | Mar 5, 2018 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: